Competitive Analysis:
Leading players in the global diabetic nephropathy market include Mitsubishi Tanabe Pharma Corporation, Siemens AG, GE, Eli Lilly and Company, AbbVie Inc., Pfizer Inc., Reata Pharmaceuticals Inc., Novartis AG, Sanofi, Abbott, Bayer AG, and Merck ... Read more